LB Pharmaceuticals' Unattributed - IV Round

LB Pharmaceuticals raised a round of funding on May 29, 2018.

LB Pharmaceuticals is a drug development company focused on development treatments for CNS disorders. LB currently has two drugs in its' pipeline. LB-101 is existing anti-psychotic currently marketed …

Articles about LB Pharmaceuticals' Unattributed - IV Round: